Circulating cell-free DNA-based epigenetic assay can detect early breast cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Circulating cell-free DNA-based epigenetic assay can detect early breast cancer ; volume:18 ; number:1 ; day:19 ; month:12 ; year:2016 ; pages:1-14 ; date:12.2016
Breast cancer research ; 18, Heft 1 (19.12.2016), 1-14, 12.2016
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Uehiro, Natsue
- Beteiligte Personen und Organisationen
-
Sato, Fumiaki
Pu, Fengling
Tanaka, Sunao
Kawashima, Masahiro
Kawaguchi, Kosuke
Sugimoto, Masahiro
Saji, Shigehira
Toi, Masakazu
SpringerLink (Online service)
- DOI
-
10.1186/s13058-016-0788-z
- URN
-
urn:nbn:de:1111-201702063861
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Uehiro, Natsue
- Sato, Fumiaki
- Pu, Fengling
- Tanaka, Sunao
- Kawashima, Masahiro
- Kawaguchi, Kosuke
- Sugimoto, Masahiro
- Saji, Shigehira
- Toi, Masakazu
- SpringerLink (Online service)
Ähnliche Objekte (12)
Integrated epigenetic biomarkers in circulating cell-free DNA as a robust classifier for pancreatic cancer
Designing circulating tumor DNA-based interventional clinical trials in oncology
Cell-free circulating tumor DNA in cancer
Quantifying circulating cell-free DNA in humans
Circulating cell-free DNA use for diagnosing cholangiocarcinoma
Multi-dimensional cell-free DNA-based liquid biopsy for sensitive early detection of gastric cancer
Circulating DNA‐Based Sequencing Guided Anlotinib Therapy in Non‐Small Cell Lung Cancer
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
New approaches for detecting cancer with circulating cell-free DNA
Circulating cell-free DNA and its clinical utility in cancer
DNA-based Nanoelectromechanical Systems
Profiling disease and tissue-specific epigenetic signatures in cell-free DNA
Integrated epigenetic biomarkers in circulating cell-free DNA as a robust classifier for pancreatic cancer
Designing circulating tumor DNA-based interventional clinical trials in oncology
Cell-free circulating tumor DNA in cancer
Quantifying circulating cell-free DNA in humans
Circulating cell-free DNA use for diagnosing cholangiocarcinoma
Multi-dimensional cell-free DNA-based liquid biopsy for sensitive early detection of gastric cancer
Circulating DNA‐Based Sequencing Guided Anlotinib Therapy in Non‐Small Cell Lung Cancer
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
New approaches for detecting cancer with circulating cell-free DNA
Circulating cell-free DNA and its clinical utility in cancer
DNA-based Nanoelectromechanical Systems
Profiling disease and tissue-specific epigenetic signatures in cell-free DNA
Integrated epigenetic biomarkers in circulating cell-free DNA as a robust classifier for pancreatic cancer
Designing circulating tumor DNA-based interventional clinical trials in oncology
Cell-free circulating tumor DNA in cancer
Quantifying circulating cell-free DNA in humans
Circulating cell-free DNA use for diagnosing cholangiocarcinoma
Multi-dimensional cell-free DNA-based liquid biopsy for sensitive early detection of gastric cancer
Circulating DNA‐Based Sequencing Guided Anlotinib Therapy in Non‐Small Cell Lung Cancer
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
New approaches for detecting cancer with circulating cell-free DNA
Circulating cell-free DNA and its clinical utility in cancer
DNA-based Nanoelectromechanical Systems